Traumatic Brain Injury-related voiding dysfunction in mice is caused by damage to rostral pathways, altering inputs to the reflex pathways.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
14 06 2019
Historique:
received: 29 11 2018
accepted: 04 06 2019
entrez: 16 6 2019
pubmed: 16 6 2019
medline: 21 10 2020
Statut: epublish

Résumé

Brain degeneration, including that caused by traumatic brain injury (TBI) often leads to severe bladder dysfunction, including incontinence and lower urinary tract symptoms; with the causes remaining unknown. Male C57BL/6J mice underwent repetitive moderate brain injury (rmdTBI) or sham injury, then mice received either cis P-tau monoclonal antibody (cis mAb), which prevents brain degeneration in TBI mice, or control (IgG). Void spot assays revealed age-dependent incontinence in IgG controls 8 months after injury, while cis mAb treated or sham mice showed no dysfunction. No obvious bladder pathology occurred in any group. Urodynamic cystometry in conscious mice revealed overactive bladder, reduced maximal voiding pressures and incontinence in IgG control, but not sham or cis mAb treated mice. Hyperphosphorylated tau deposition and neural tangle-like pathology occurred in cortical and hippocampal regions only of IgG control mice accompanied with post-traumatic neuroinflammation and was not seen in midbrain and hindbrain regions associated with bladder filling and voiding reflex arcs. In this model of brain degeneration bladder dysfunction results from rostral, and not hindbrain damage, indicating that rostral brain inputs are required for normal bladder functioning. Detailed analysis of the functioning of neural circuits controlling bladder function in TBI should lead to insights into how brain degeneration leads to bladder dysfunction, as well as novel strategies to treat these disorders.

Identifiants

pubmed: 31201348
doi: 10.1038/s41598-019-45234-8
pii: 10.1038/s41598-019-45234-8
pmc: PMC6570649
doi:

Substances chimiques

tau Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

8646

Subventions

Organisme : NIA NIH HHS
ID : R01 AG055559
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS096835
Pays : United States

Références

Brain. 2013 Jan;136(Pt 1):43-64
pubmed: 23208308
J Alzheimers Dis Parkinsonism. 2018;8(3):
pubmed: 30197831
Nature. 2015 Jul 23;523(7561):431-436
pubmed: 26176913
Curr Bladder Dysfunct Rep. 2015 Dec 1;10(4):325-331
pubmed: 26715948
Handb Clin Neurol. 2015;130:335-56
pubmed: 26003253
Compr Physiol. 2015 Jan;5(1):327-96
pubmed: 25589273
Exp Neurol. 2013 Feb;240:57-63
pubmed: 23178579
Arch Phys Med Rehabil. 2003 Mar;84(3):343-9
pubmed: 12638101
J Neurochem. 2011 Aug;118(4):658-67
pubmed: 21644996
Toxicology. 1997 Jul 25;121(1):17-28
pubmed: 9217312
J Neurotrauma. 2014 Mar 1;31(5):487-97
pubmed: 24041015
Neurosci Lett. 1997 Feb 7;222(3):195-8
pubmed: 9148248
J Biol Chem. 2013 Nov 15;288(46):33081-95
pubmed: 24089520
Brain Inj. 2000 Feb;14(2):141-52
pubmed: 10695570
Mol Cell. 2000 Oct;6(4):873-83
pubmed: 11090625
Neurology. 1999 Dec 10;53(9):1959-62
pubmed: 10599765
Neurobiol Dis. 2013 Jun;54:252-63
pubmed: 23313314
Lab Anim. 1971 Oct;5(2):163-7
pubmed: 5166567
Nat Rev Neurol. 2013 Apr;9(4):192-200
pubmed: 23558985
Arch Phys Med Rehabil. 2011 Jul;92(7):1134-8
pubmed: 21704794
Cell. 2012 Mar 30;149(1):232-44
pubmed: 22464332
Am J Physiol Renal Physiol. 2015 Jun 15;308(12):F1369-78
pubmed: 25904700
J Neuroinflammation. 2012 Feb 28;9:43
pubmed: 22373400
Nat Rev Neurol. 2013 Apr;9(4):211-21
pubmed: 23458973
Nat Cell Biol. 2009 Jul;11(7):909-13
pubmed: 19503072
Brain Inj. 2011;25(7-8):664-79
pubmed: 21561297
Neuroscience. 1994 Sep;62(1):125-43
pubmed: 7816195
Ann Neurol. 2015 Jun;77(6):987-95
pubmed: 25726936
Nat Protoc. 2009;4(9):1328-37
pubmed: 19713954
Am J Physiol Regul Integr Comp Physiol. 2012 Mar 1;302(5):R577-86
pubmed: 22204955
Cell Biosci. 2016 Dec 5;6:59
pubmed: 27980715
Nat Commun. 2017 Oct 17;8(1):1000
pubmed: 29042562
Pharmacol Ther. 2011 May;130(2):106-13
pubmed: 21256863
PLoS One. 2018 Aug 16;13(8):e0202566
pubmed: 30114280
J Head Trauma Rehabil. 2017 May/Jun;32(3):158-167
pubmed: 27455433
Brain Inj. 2017;31(9):1177-1182
pubmed: 28981345
Nat Rev Urol. 2015 Dec;12(12):695-705
pubmed: 26620610
J Neurosurg. 2016 Mar;124(3):703-9
pubmed: 26473787
JAMA. 2014 May 14;311(18):1917-9
pubmed: 24825648
Neurology. 2000 Mar 28;54(6):1316-23
pubmed: 10746604
Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):11256-61
pubmed: 21690345
Arch Phys Med Rehabil. 1996 Jul;77(7):639-44
pubmed: 8669988
Neurology. 1986 Jul;36(7):922-31
pubmed: 3714054
Am J Physiol Renal Physiol. 2014 Jun 1;306(11):F1296-307
pubmed: 24717733
Parkinsonism Relat Disord. 2016 Jan;22:21-7
pubmed: 26620547
Brain Behav Immun. 2017 Feb;60:369-382
pubmed: 27686843
Nat Rev Neurol. 2016 Aug;12(8):486-90
pubmed: 27364748
Semin Neurol. 2015 Feb;35(1):83-100
pubmed: 25714870
J Neurotrauma. 2005 Oct;22(10):1134-41
pubmed: 16238489
Science. 1973 Nov 20;182(4115):939-41
pubmed: 4745598
J Head Trauma Rehabil. 2006 Sep-Oct;21(5):375-8
pubmed: 16983222
J Biol Chem. 2011 Sep 30;286(39):34457-67
pubmed: 21841002
JAMA Neurol. 2014 Dec;71(12):1490-7
pubmed: 25347255
Science. 2011 Jul 29;333(6042):514-7
pubmed: 21798909
J Clin Invest. 2008 May;118(5):1877-89
pubmed: 18431510
J Comp Neurol. 2017 Jul 1;525(10):2287-2309
pubmed: 28340519
Brain Inj. 2003 Jun;17(6):469-78
pubmed: 12745703
Cell. 2016 Sep 22;167(1):73-86.e12
pubmed: 27662084
J Neurosci Methods. 2012 Jan 15;203(1):41-9
pubmed: 21930157
Acta Neuropathol Commun. 2018 Dec 18;6(1):140
pubmed: 30563563
Ann Neurol. 2014 Mar;75(3):374-81
pubmed: 24812697
J Neurosci. 2014 Mar 19;34(12):4260-72
pubmed: 24647946
Nature. 1999 Jun 24;399(6738):784-8
pubmed: 10391244
Neuron. 2012 Dec 6;76(5):886-99
pubmed: 23217738
J Rehabil Med. 2016 Apr 28;48(5):442-8
pubmed: 27058885
Handb Clin Neurol. 2015;130:269-87
pubmed: 26003249
Neurosci Lett. 1994 Jan 17;166(1):93-6
pubmed: 7514777
Nat Rev Neurosci. 2008 Jun;9(6):453-66
pubmed: 18490916
JAMA. 2017 Jul 25;318(4):360-370
pubmed: 28742910
Neurourol Urodyn. 2014 Sep;33(7):1159-64
pubmed: 24038177
Nat Med. 2017 Jun;23(6):782-787
pubmed: 28481360
Front Neurol. 2013 Aug 14;4:119
pubmed: 23966976
Nat Rev Neurosci. 2010 Mar;11(3):155-9
pubmed: 20029438
Acta Physiol (Oxf). 2013 Jan;207(1):66-84
pubmed: 23033877
Handb Clin Neurol. 2015;130:121-33
pubmed: 26003241
Neuron. 2013 Oct 16;80(2):402-414
pubmed: 24075978
J Rehabil Res Dev. 2007;44(7):975-82
pubmed: 18075954
Sci Transl Med. 2012 May 16;4(134):134ra60
pubmed: 22593173
Neuron. 2012 Feb 23;73(4):685-97
pubmed: 22365544
Nature. 2011 Sep 21;477(7365):390-3
pubmed: 21938046
MMWR Surveill Summ. 2017 Mar 17;66(9):1-16
pubmed: 28301451

Auteurs

Onder Albayram (O)

Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, SC, 29425, USA. albayram@musc.edu.
Hematology and Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA. albayram@musc.edu.
Division of Translational Therapeutics, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA. albayram@musc.edu.
Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA. albayram@musc.edu.

Bryce MacIver (B)

Division of Nephrology, Department of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA. imaciver@bidmc.harvard.edu.

John Mathai (J)

Division of Nephrology, Department of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.

Anne Verstegen (A)

Division of Nephrology, Department of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.

Sean Baxley (S)

Hematology and Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
Division of Translational Therapeutics, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.

Chenxi Qiu (C)

Hematology and Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
Division of Translational Therapeutics, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.

Carter Bell (C)

Hematology and Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
Division of Translational Therapeutics, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.

Barbara J Caldarone (BJ)

NeuroBehavior Laboratory, Harvard NeuroDiscovery Center, Harvard Medical School, Boston, MA, 02115, USA.

Xiao Zhen Zhou (XZ)

Hematology and Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
Division of Translational Therapeutics, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.

Kun Ping Lu (KP)

Hematology and Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
Division of Translational Therapeutics, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.

Mark Zeidel (M)

Division of Nephrology, Department of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH